Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
TG Therapeutics, Samsung Biologics expand collaboration for ublituximab » 07:03
04/26/21
04/26
07:03
04/26/21
07:03
TGTX

TG Therapeutics

$42.38 /

+1.3 (+3.16%)

Samsung Biologics and TG…

Samsung Biologics and TG Therapeutics announced an expansion of a large-scale contract manufacturing deal for the supply of TG Therapeutics' ublituximab, an investigational anti-CD20 monoclonal antibody. TG Therapeutics has completed a rolling submission of a Biologics License Application to the Food and Drug Administration requesting approval of ublituximab, in combination with UKONIQ, TG Therapeutics' oral once-daily inhibitor of PI3K-delta and CK1-epsilon, as a treatment for patients with CLL, based primarily on the results from the UNITY-CLL Phase 3 trial. Ublituximab was also the subject of two Phase 3 trials in patients with relapsing forms of multiple sclerosis and a BLA is currently being prepared for this indication.

ShowHide Related Items >><<
TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

  • 15
    Dec
  • 15
    May
TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

Hot Stocks
Samsung Biologics, TG Therapeutics expand large scale manufacturing deal » 19:59
04/25/21
04/25
19:59
04/25/21
19:59
TGTX

TG Therapeutics

$42.38 /

+1.3 (+3.16%)

Samsung Biologics and TG…

Samsung Biologics and TG Therapeutics announced an expansion of a large-scale contract manufacturing deal for the supply of TG Therapeutics' ublituximab, an investigational anti-CD20 monoclonal antibody. TG Therapeutics has completed a rolling submission of a Biologics License Application to the U.S. Food and Drug Administration requesting approval of ublituximab, in combination with UKONIQ, TG Therapeutics' oral once-daily inhibitor of PI3K-delta and CK1-epsilon, as a treatment for patients with CLL, based primarily on the positive results from the UNITY-CLL Phase 3 trial. Ublituximab was also the subject of two successful Phase 3 trials in patients with relapsing forms of multiple sclerosis and a BLA is currently being prepared for this indication.

ShowHide Related Items >><<
TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

  • 15
    Dec
  • 15
    May
TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

TGTX TG Therapeutics
$42.38 /

+1.3 (+3.16%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 04:55
04/22/21
04/22
04:55
04/22/21
04:55
ABBV

AbbVie

$110.81 /

+1.78 (+1.63%)

, ABC

AmerisourceBergen

$121.16 /

+0.69 (+0.57%)

, ABT

Abbott

$122.61 /

+2.62 (+2.18%)

, ACAD

Acadia Pharmaceuticals

$21.46 /

+0.67 (+3.22%)

, ALNY

Alnylam

$137.67 /

+2 (+1.47%)

, BIIB

Biogen

$269.13 /

-3.84 (-1.41%)

, BMY

Bristol-Myers

$66.32 /

+0.265 (+0.40%)

, BHVN

Biohaven Pharmaceutical

$75.13 /

+1.5 (+2.04%)

, CPRX

Catalyst Pharmaceuticals

$4.52 /

+0.13 (+2.96%)

, DGX

Quest Diagnostics

$130.08 /

+0.79 (+0.61%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$93.52 /

+2.45 (+2.69%)

, LIVN

LivaNova

$83.05 /

+1.63 (+2.00%)

, LLY

Eli Lilly

$191.00 /

+0.45 (+0.24%)

, MDT

Medtronic

$130.19 /

+1.9 (+1.48%)

, NVS

Novartis

$88.67 /

+0.84 (+0.96%)

, NVTA

Invitae

$36.05 /

+1.795 (+5.24%)

, PFE

Pfizer

$39.53 /

+0.5 (+1.28%)

, PTCT

PTC Therapeutics

$45.78 /

-0.545 (-1.18%)

, RETA

Reata Pharmaceuticals

$90.75 /

+1.17 (+1.31%)

, SNY

Sanofi

$52.43 /

+0.44 (+0.85%)

, SUPN

Supernus

$31.37 /

+0.61 (+1.98%)

, TAK

Takeda Pharmaceutical

$16.93 /

+0.095 (+0.56%)

, TEVA

Teva

$10.25 /

+0.135 (+1.33%)

, TGTX

TG Therapeutics

$40.61 /

+0.64 (+1.60%)

, ZGNX

Zogenix

$18.95 /

+0.09 (+0.48%)

, AVDL

Avadel Pharmaceuticals

$8.46 /

+0.265 (+3.24%)

, JNJ

Johnson & Johnson

$166.61 /

+0.16 (+0.10%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

SUPN Supernus
$31.37 /

+0.61 (+1.98%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

ALNY Alnylam
$137.67 /

+2 (+1.47%)

ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$122.61 /

+2.62 (+2.18%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$137.67 /

+2 (+1.47%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$269.13 /

-3.84 (-1.41%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$130.19 /

+1.9 (+1.48%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.67 /

+0.84 (+0.96%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$36.05 /

+1.795 (+5.24%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$39.53 /

+0.5 (+1.28%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$52.43 /

+0.44 (+0.85%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.37 /

+0.61 (+1.98%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.25 /

+0.135 (+1.33%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

SUPN Supernus
$31.37 /

+0.61 (+1.98%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

ALNY Alnylam
$137.67 /

+2 (+1.47%)

ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.25 /

+0.135 (+1.33%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

LIVN LivaNova
$83.05 /

+1.63 (+2.00%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

ALNY Alnylam
$137.67 /

+2 (+1.47%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

SUPN Supernus
$31.37 /

+0.61 (+1.98%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RETA Reata Pharmaceuticals
$90.75 /

+1.17 (+1.31%)

PTCT PTC Therapeutics
$45.78 /

-0.545 (-1.18%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

CPRX Catalyst Pharmaceuticals
$4.52 /

+0.13 (+2.96%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

BHVN Biohaven Pharmaceutical
$75.13 /

+1.5 (+2.04%)

AVDL Avadel Pharmaceuticals
$8.46 /

+0.265 (+3.24%)

ACAD Acadia Pharmaceuticals
$21.46 /

+0.67 (+3.22%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

ZGNX Zogenix
$18.95 /

+0.09 (+0.48%)

TGTX TG Therapeutics
$40.61 /

+0.64 (+1.60%)

TEVA Teva
$10.25 /

+0.135 (+1.33%)

TAK Takeda Pharmaceutical
$16.93 /

+0.095 (+0.56%)

PFE Pfizer
$39.53 /

+0.5 (+1.28%)

NVTA Invitae
$36.05 /

+1.795 (+5.24%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

JNJ Johnson & Johnson
$166.61 /

+0.16 (+0.10%)

HZNP Horizon Therapeutics
$93.52 /

+2.45 (+2.69%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

BMY Bristol-Myers
$66.32 /

+0.265 (+0.40%)

BIIB Biogen
$269.13 /

-3.84 (-1.41%)

ABT Abbott
$122.61 /

+2.62 (+2.18%)

ABC AmerisourceBergen
$121.16 /

+0.69 (+0.57%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

Hot Stocks
TG Therapeutics announces launch of ULTRA-V phase 3 trial » 07:10
04/21/21
04/21
07:10
04/21/21
07:10
TGTX

TG Therapeutics

$39.95 /

-2.88 (-6.72%)

TG Therapeutics announced…

TG Therapeutics announced the initiation of patient enrollment into the ULTRA-V Phase 3 randomized trial, evaluating the time-limited triple combination of UKONIQ, the company's once-daily, inhibitor of PI3K-delta and CK1-epsilon, ublituximab, the company's investigational glycoengineered anti-CD20 monoclonal antibody, and venetoclax, compared to the continuous doublet combination of UKONIQ plus ublituximab, or U2, in patients with both frontline and relapsed or refractory chronic lymphocytic leukemia, or CLL. The primary endpoint for the ULTRA-V Phase 3 trial is Progression-free Survival, and the trial is designed support the full approval of the triple combination of U2 plus venetoclax. The company also announced completion of enrollment into the ULTRA-V Phase 2 global, single arm trial evaluating the triple combination of U2 plus venetoclax. This primary endpoint for this trial is overall response rate and complete response rate, and the trial completed enrollment with approximately 165 patients enrolled.

ShowHide Related Items >><<
TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

  • 15
    Dec
  • 15
    May
TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
ABBV

AbbVie

$109.03 /

+0.43 (+0.40%)

, ABC

AmerisourceBergen

$120.47 /

+0.98 (+0.82%)

, ABT

Abbott

$120.00 /

-4.67 (-3.75%)

, ACAD

Acadia Pharmaceuticals

$20.79 /

+0.01 (+0.05%)

, ALNY

Alnylam

$135.74 /

-1.55 (-1.13%)

, BIIB

Biogen

$272.95 /

+4.05 (+1.51%)

, BMY

Bristol-Myers

$66.06 /

+0.4 (+0.61%)

, BHVN

Biohaven Pharmaceutical

$73.50 /

+1.22 (+1.69%)

, CPRX

Catalyst Pharmaceuticals

$4.39 /

+0.07 (+1.62%)

, DGX

Quest Diagnostics

$129.37 /

-1.69 (-1.29%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$91.07 /

+0.88 (+0.98%)

, LIVN

LivaNova

$81.39 /

+0.74 (+0.92%)

, LLY

Eli Lilly

$190.55 /

+0.85 (+0.45%)

, MDT

Medtronic

$128.29 /

+2.13 (+1.69%)

, NVS

Novartis

$87.84 /

-0.52 (-0.59%)

, NVTA

Invitae

$34.25 /

-1.08 (-3.06%)

, PFE

Pfizer

$39.03 /

+0.09 (+0.23%)

, PTCT

PTC Therapeutics

$46.26 /

-1.27 (-2.67%)

, RETA

Reata Pharmaceuticals

$89.28 /

-1.62 (-1.78%)

, SNY

Sanofi

$51.98 /

+0.12 (+0.23%)

, SUPN

Supernus

$30.69 /

-0.24 (-0.78%)

, TAK

Takeda Pharmaceutical

$16.84 /

-0.12 (-0.71%)

, TEVA

Teva

$10.12 /

-0.175 (-1.70%)

, TGTX

TG Therapeutics

$39.95 /

-2.88 (-6.72%)

, ZGNX

Zogenix

$18.79 /

-0.1 (-0.53%)

, AVDL

Avadel Pharmaceuticals

$8.17 /

-0.3 (-3.54%)

, JNJ

Johnson & Johnson

$166.47 /

+3.66 (+2.25%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$120.00 /

-4.67 (-3.75%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$272.95 /

+4.05 (+1.51%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$128.29 /

+2.13 (+1.69%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$87.84 /

-0.52 (-0.59%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$34.25 /

-1.08 (-3.06%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$39.03 /

+0.09 (+0.23%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.98 /

+0.12 (+0.23%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$30.69 /

-0.24 (-0.78%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.12 /

-0.175 (-1.70%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.12 /

-0.175 (-1.70%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

LIVN LivaNova
$81.39 /

+0.74 (+0.92%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

ALNY Alnylam
$135.74 /

-1.55 (-1.13%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

SUPN Supernus
$30.69 /

-0.24 (-0.78%)

SNY Sanofi
$51.98 /

+0.12 (+0.23%)

RETA Reata Pharmaceuticals
$89.28 /

-1.62 (-1.78%)

PTCT PTC Therapeutics
$46.26 /

-1.27 (-2.67%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

NVS Novartis
$87.84 /

-0.52 (-0.59%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

CPRX Catalyst Pharmaceuticals
$4.39 /

+0.07 (+1.62%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

BHVN Biohaven Pharmaceutical
$73.50 /

+1.22 (+1.69%)

AVDL Avadel Pharmaceuticals
$8.17 /

-0.3 (-3.54%)

ACAD Acadia Pharmaceuticals
$20.79 /

+0.01 (+0.05%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

ZGNX Zogenix
$18.79 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$39.95 /

-2.88 (-6.72%)

TEVA Teva
$10.12 /

-0.175 (-1.70%)

TAK Takeda Pharmaceutical
$16.84 /

-0.12 (-0.71%)

PFE Pfizer
$39.03 /

+0.09 (+0.23%)

NVTA Invitae
$34.25 /

-1.08 (-3.06%)

MDT Medtronic
$128.29 /

+2.13 (+1.69%)

LLY Eli Lilly
$190.55 /

+0.85 (+0.45%)

JNJ Johnson & Johnson
$166.47 /

+3.66 (+2.25%)

HZNP Horizon Therapeutics
$91.07 /

+0.88 (+0.98%)

DGX Quest Diagnostics
$129.37 /

-1.69 (-1.29%)

BMY Bristol-Myers
$66.06 /

+0.4 (+0.61%)

BIIB Biogen
$272.95 /

+4.05 (+1.51%)

ABT Abbott
$120.00 /

-4.67 (-3.75%)

ABC AmerisourceBergen
$120.47 /

+0.98 (+0.82%)

ABBV AbbVie
$109.03 /

+0.43 (+0.40%)

Initiation
Fly Intel: Top five analyst initiations » 09:58
04/20/21
04/20
09:58
04/20/21
09:58
UBER

Uber

$57.14 /

-0.71 (-1.23%)

, HPE

HP Enterprise

$15.81 /

-0.15 (-0.94%)

, TGTX

TG Therapeutics

$41.28 /

-1.55 (-3.62%)

, CSCO

Cisco

$52.15 /

-0.73 (-1.38%)

, RNG

RingCentral

$328.50 /

+9.42 (+2.95%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Uber (UBER) initiated with a Buy at Nomura. 2. HP Enterprise (HPE) initiated with a Buy at Jefferies. 3. TG Therapeutics (TGTX) initiated with a Neutral at Goldman Sachs. 4. Cisco (CSCO) initiated with a Hold at Deutsche Bank. 5. RingCentral (RNG) reinstated with a Buy at BofA. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
UBER Uber
$57.14 /

-0.71 (-1.23%)

TGTX TG Therapeutics
$41.28 /

-1.55 (-3.62%)

RNG RingCentral
$328.50 /

+9.42 (+2.95%)

HPE HP Enterprise
$15.81 /

-0.15 (-0.94%)

CSCO Cisco
$52.15 /

-0.73 (-1.38%)

UBER Uber
$57.14 /

-0.71 (-1.23%)

04/20/21 Nomura
Uber initiated with a Buy at Nomura
04/12/21 Truist
Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist
04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
HPE HP Enterprise
$15.81 /

-0.15 (-0.94%)

04/20/21 Jefferies
HP Enterprise initiated with a Buy at Jefferies
04/08/21 Morgan Stanley
HP Enterprise price target raised to $17 from $15.50 at Morgan Stanley
03/26/21 JPMorgan
HP Enterprise price target raised to $18 from $17 at JPMorgan
03/10/21
Fly Intel: Top five analyst upgrades
TGTX TG Therapeutics
$41.28 /

-1.55 (-3.62%)

04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
CSCO Cisco
$52.15 /

-0.73 (-1.38%)

04/20/21 B. Riley
B. Riley says buy NeoPhotonics as 'industry titans clash'
04/20/21 Deutsche Bank
Cisco initiated with a Hold at Deutsche Bank
04/16/21 Wolfe Research
Cisco upgraded to Outperform amid resurgence of IT spending at Wolfe Research
04/16/21 Wolfe Research
Cisco upgraded to Outperform from Peer Perform at Wolfe Research
RNG RingCentral
$328.50 /

+9.42 (+2.95%)

04/20/21 BofA
RingCentral reinstated with a Buy at BofA
04/20/21 BofA
RingCentral reinstated with a Buy at BofA
03/18/21 William Blair
RingCentral granted temporary restraining order in Zoom case, says William Blair
03/16/21 Craig-Hallum
RingCentral price target lowered to $410 from $530 at Craig-Hallum
UBER Uber
$57.14 /

-0.71 (-1.23%)

TGTX TG Therapeutics
$41.28 /

-1.55 (-3.62%)

RNG RingCentral
$328.50 /

+9.42 (+2.95%)

HPE HP Enterprise
$15.81 /

-0.15 (-0.94%)

CSCO Cisco
$52.15 /

-0.73 (-1.38%)

  • 08
    Jan
  • 15
    Dec
  • 15
    May
UBER Uber
$57.14 /

-0.71 (-1.23%)

CSCO Cisco
$52.15 /

-0.73 (-1.38%)

UBER Uber
$57.14 /

-0.71 (-1.23%)

TGTX TG Therapeutics
$41.28 /

-1.55 (-3.62%)

RNG RingCentral
$328.50 /

+9.42 (+2.95%)

HPE HP Enterprise
$15.81 /

-0.15 (-0.94%)

CSCO Cisco
$52.15 /

-0.73 (-1.38%)

UBER Uber
$57.14 /

-0.71 (-1.23%)

TGTX TG Therapeutics
$41.28 /

-1.55 (-3.62%)

HPE HP Enterprise
$15.81 /

-0.15 (-0.94%)

CSCO Cisco
$52.15 /

-0.73 (-1.38%)

Initiation
TG Therapeutics initiated with a Neutral at Goldman Sachs » 04:56
04/20/21
04/20
04:56
04/20/21
04:56
TGTX

TG Therapeutics

$42.83 /

-1.88 (-4.20%)

Goldman Sachs analyst…

Goldman Sachs analyst Graig Suvannavejh initiated coverage of TG Therapeutics with a Neutral rating and $50 price target. The analyst sees "risk in small company product launches" and has a below consensus view on the company's 2021-2024 product sales. As such, he prefers to take a "wait and see approach" on the launches.

ShowHide Related Items >><<
TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

  • 15
    Dec
  • 15
    May
TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 04:55
04/20/21
04/20
04:55
04/20/21
04:55
ABBV

AbbVie

$108.66 /

+0.73 (+0.68%)

, ABC

AmerisourceBergen

$119.49 /

-0.02 (-0.02%)

, ABT

Abbott

$124.67 /

+0.3 (+0.24%)

, ACAD

Acadia Pharmaceuticals

$20.78 /

-0.39 (-1.84%)

, ALNY

Alnylam

$137.25 /

-1.535 (-1.11%)

, BIIB

Biogen

$268.99 /

-1.23 (-0.46%)

, BMY

Bristol-Myers

$65.66 /

+0.2 (+0.31%)

, BHVN

Biohaven Pharmaceutical

$72.23 /

-2.135 (-2.87%)

, CPRX

Catalyst Pharmaceuticals

$4.32 /

-0.115 (-2.59%)

, DGX

Quest Diagnostics

$130.97 /

+0.86 (+0.66%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$90.26 /

-3.06 (-3.28%)

, LIVN

LivaNova

$80.65 /

-0.7 (-0.86%)

, LLY

Eli Lilly

$189.86 /

+0.58 (+0.31%)

, MDT

Medtronic

$126.16 /

+0.25 (+0.20%)

, NVS

Novartis

$88.36 /

+0.335 (+0.38%)

, NVTA

Invitae

$35.34 /

-2.31 (-6.14%)

, PFE

Pfizer

$38.94 /

+0.37 (+0.96%)

, PTCT

PTC Therapeutics

$47.53 /

-1.01 (-2.08%)

, RETA

Reata Pharmaceuticals

$91.38 /

+0.55 (+0.61%)

, SNY

Sanofi

$51.86 /

+0.56 (+1.09%)

, SUPN

Supernus

$30.93 /

-0.82 (-2.58%)

, TAK

Takeda Pharmaceutical

$16.95 /

-0.115 (-0.67%)

, TEVA

Teva

$10.29 /

-0.46 (-4.28%)

, TGTX

TG Therapeutics

$42.83 /

-1.88 (-4.20%)

, ZGNX

Zogenix

$18.89 /

-0.1 (-0.53%)

, AVDL

Avadel Pharmaceuticals

$8.47 /

-0.18 (-2.08%)

, JNJ

Johnson & Johnson

$162.98 /

+0.83 (+0.51%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

SUPN Supernus
$30.93 /

-0.82 (-2.58%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

MDT Medtronic
$126.16 /

+0.25 (+0.20%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$124.67 /

+0.3 (+0.24%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$268.99 /

-1.23 (-0.46%)

04/19/21 Jefferies
Biogen 'may have best risk/reward among large caps' in 2021-23, says Jefferies
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

04/19/21 Piper Sandler
LivaNova HF enrollment milestone a key step toward approval, says Piper Sandler
04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$126.16 /

+0.25 (+0.20%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.36 /

+0.335 (+0.38%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
NVTA Invitae
$35.34 /

-2.31 (-6.14%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$38.94 /

+0.37 (+0.96%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.86 /

+0.56 (+1.09%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$30.93 /

-0.82 (-2.58%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.29 /

-0.46 (-4.28%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

SUPN Supernus
$30.93 /

-0.82 (-2.58%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

MDT Medtronic
$126.16 /

+0.25 (+0.20%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.29 /

-0.46 (-4.28%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

LIVN LivaNova
$80.65 /

-0.7 (-0.86%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

ALNY Alnylam
$137.25 /

-1.535 (-1.11%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

SUPN Supernus
$30.93 /

-0.82 (-2.58%)

SNY Sanofi
$51.86 /

+0.56 (+1.09%)

RETA Reata Pharmaceuticals
$91.38 /

+0.55 (+0.61%)

PTCT PTC Therapeutics
$47.53 /

-1.01 (-2.08%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

NVS Novartis
$88.36 /

+0.335 (+0.38%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

CPRX Catalyst Pharmaceuticals
$4.32 /

-0.115 (-2.59%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

BHVN Biohaven Pharmaceutical
$72.23 /

-2.135 (-2.87%)

AVDL Avadel Pharmaceuticals
$8.47 /

-0.18 (-2.08%)

ACAD Acadia Pharmaceuticals
$20.78 /

-0.39 (-1.84%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

ZGNX Zogenix
$18.89 /

-0.1 (-0.53%)

TGTX TG Therapeutics
$42.83 /

-1.88 (-4.20%)

TEVA Teva
$10.29 /

-0.46 (-4.28%)

TAK Takeda Pharmaceutical
$16.95 /

-0.115 (-0.67%)

PFE Pfizer
$38.94 /

+0.37 (+0.96%)

NVTA Invitae
$35.34 /

-2.31 (-6.14%)

MDT Medtronic
$126.16 /

+0.25 (+0.20%)

LLY Eli Lilly
$189.86 /

+0.58 (+0.31%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

HZNP Horizon Therapeutics
$90.26 /

-3.06 (-3.28%)

DGX Quest Diagnostics
$130.97 /

+0.86 (+0.66%)

BMY Bristol-Myers
$65.66 /

+0.2 (+0.31%)

BIIB Biogen
$268.99 /

-1.23 (-0.46%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

ABC AmerisourceBergen
$119.49 /

-0.02 (-0.02%)

ABBV AbbVie
$108.66 /

+0.73 (+0.68%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 09:24
04/19/21
04/19
09:24
04/19/21
09:24
ABBV

AbbVie

$107.93 /

+1.05 (+0.98%)

, ABC

AmerisourceBergen

$119.62 /

+0.55 (+0.46%)

, ABT

Abbott

$124.37 /

+0.4 (+0.32%)

, ACAD

Acadia Pharmaceuticals

$21.17 /

-0.02 (-0.09%)

, ALNY

Alnylam

$138.69 /

-0.23 (-0.17%)

, BIIB

Biogen

$270.07 /

-0.66 (-0.24%)

, BMY

Bristol-Myers

$65.46 /

+1.02 (+1.58%)

, BHVN

Biohaven Pharmaceutical

$74.37 /

-1.435 (-1.89%)

, CPRX

Catalyst Pharmaceuticals

$4.44 /

-0.02 (-0.45%)

, DGX

Quest Diagnostics

$130.09 /

+0.86 (+0.67%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$93.25 /

-0.32 (-0.34%)

, LIVN

LivaNova

$81.37 /

-1.46 (-1.76%)

, LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

, MDT

Medtronic

$125.91 /

+0.06 (+0.05%)

, NVS

Novartis

$88.02 /

+0.81 (+0.93%)

, NVTA

Invitae

$37.65 /

-1.47 (-3.76%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

, PTCT

PTC Therapeutics

$48.48 /

+0.33 (+0.69%)

, RETA

Reata Pharmaceuticals

$90.83 /

-1.29 (-1.40%)

, SNY

Sanofi

$51.29 /

+0.63 (+1.24%)

, SUPN

Supernus

$31.72 /

-0.09 (-0.28%)

, TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

, TEVA

Teva

$10.75 /

-0.08 (-0.74%)

, TGTX

TG Therapeutics

$44.79 /

-1.05 (-2.29%)

, ZGNX

Zogenix

$19.00 /

-0.65 (-3.31%)

, AVDL

Avadel Pharmaceuticals

$8.65 /

+0.09 (+1.05%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$124.37 /

+0.4 (+0.32%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$270.07 /

-0.66 (-0.24%)

04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
03/03/21 Berenberg
LivaNova downgraded to Hold from Buy at Berenberg
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$125.91 /

+0.06 (+0.05%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.02 /

+0.81 (+0.93%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
NVTA Invitae
$37.65 /

-1.47 (-3.76%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.29 /

+0.63 (+1.24%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.72 /

-0.09 (-0.28%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.75 /

-0.08 (-0.74%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.75 /

-0.08 (-0.74%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

Recommendations
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald » 07:12
04/19/21
04/19
07:12
04/19/21
07:12
TGTX

TG Therapeutics

$44.79 /

-1.05 (-2.29%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Alethia Young raised the firm's price target on TG Therapeutics to $74 from $68 and keeps an Overweight rating on the shares. The company's recent data update showed that the ULTIMATE I and II trials hit on the primary endpoint of annualized relapse rate, and Young views the data as differentiating in MS, the analyst tells investors in a research note. Young thinks all evidence points to ublituximab being a very effective and safe therapy for relapsing MS treatment.

ShowHide Related Items >><<
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
02/08/21 H.C. Wainwright
H.C. Wainwright ups TG Therapeutics target to $79 on Ukoniq MZL, FL approval
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

  • 15
    Dec
  • 15
    May
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.